Development of Relaxin-3 Agonists and Antagonists Based on Grafted Disulfide-Stabilized Scaffolds

Relaxin-3 is a neuropeptide with important roles in metabolism, arousal, learning and memory. Its cognate receptor is the relaxin family peptide-3 (RXFP3) receptor. Relaxin-3 agonist and antagonist analogs have been shown to be able to modulate food intake in rodent models. The relaxin-3 B-chain is...

Full description

Bibliographic Details
Main Authors: Han Siean Lee, Michael Postan, Angela Song, Richard J. Clark, Ross A. D. Bathgate, Linda M. Haugaard-Kedström, K. Johan Rosengren
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Chemistry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fchem.2020.00087/full
_version_ 1818902665148497920
author Han Siean Lee
Michael Postan
Angela Song
Richard J. Clark
Ross A. D. Bathgate
Ross A. D. Bathgate
Linda M. Haugaard-Kedström
K. Johan Rosengren
author_facet Han Siean Lee
Michael Postan
Angela Song
Richard J. Clark
Ross A. D. Bathgate
Ross A. D. Bathgate
Linda M. Haugaard-Kedström
K. Johan Rosengren
author_sort Han Siean Lee
collection DOAJ
description Relaxin-3 is a neuropeptide with important roles in metabolism, arousal, learning and memory. Its cognate receptor is the relaxin family peptide-3 (RXFP3) receptor. Relaxin-3 agonist and antagonist analogs have been shown to be able to modulate food intake in rodent models. The relaxin-3 B-chain is sufficient for receptor interactions, however, in the absence of a structural support, linear relaxin-3 B-chain analogs are rapidly degraded and thus unsuitable as drug leads. In this study, two different disulfide-stabilized scaffolds were used for grafting of important relaxin-3 B-chain residues to improve structure and stability. The use of both Veronica hederifolia Trypsin inhibitor (VhTI) and apamin grafting resulted in agonist and antagonist analogs with improved helicity. VhTI grafted peptides showed poor binding and low potency at RXFP3, on the other hand, apamin variants retained significant activity. These variants also showed improved half-life in serum from ~5 min to >6 h, and thus are promising RXFP3 specific pharmacological tools and drug leads for neuropharmacological diseases.
first_indexed 2024-12-19T20:39:15Z
format Article
id doaj.art-c183aee3f6d549afbc6228b8eaf12157
institution Directory Open Access Journal
issn 2296-2646
language English
last_indexed 2024-12-19T20:39:15Z
publishDate 2020-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Chemistry
spelling doaj.art-c183aee3f6d549afbc6228b8eaf121572022-12-21T20:06:27ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462020-02-01810.3389/fchem.2020.00087495592Development of Relaxin-3 Agonists and Antagonists Based on Grafted Disulfide-Stabilized ScaffoldsHan Siean Lee0Michael Postan1Angela Song2Richard J. Clark3Ross A. D. Bathgate4Ross A. D. Bathgate5Linda M. Haugaard-Kedström6K. Johan Rosengren7Faculty of Medicine, School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, AustraliaFaculty of Medicine, School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, AustraliaFaculty of Medicine, School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, AustraliaFaculty of Medicine, School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, AustraliaFlorey Department of Neuroscience and Mental Health, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, VIC, AustraliaDepartment of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, VIC, AustraliaFaculty of Medicine, School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, AustraliaFaculty of Medicine, School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, AustraliaRelaxin-3 is a neuropeptide with important roles in metabolism, arousal, learning and memory. Its cognate receptor is the relaxin family peptide-3 (RXFP3) receptor. Relaxin-3 agonist and antagonist analogs have been shown to be able to modulate food intake in rodent models. The relaxin-3 B-chain is sufficient for receptor interactions, however, in the absence of a structural support, linear relaxin-3 B-chain analogs are rapidly degraded and thus unsuitable as drug leads. In this study, two different disulfide-stabilized scaffolds were used for grafting of important relaxin-3 B-chain residues to improve structure and stability. The use of both Veronica hederifolia Trypsin inhibitor (VhTI) and apamin grafting resulted in agonist and antagonist analogs with improved helicity. VhTI grafted peptides showed poor binding and low potency at RXFP3, on the other hand, apamin variants retained significant activity. These variants also showed improved half-life in serum from ~5 min to >6 h, and thus are promising RXFP3 specific pharmacological tools and drug leads for neuropharmacological diseases.https://www.frontiersin.org/article/10.3389/fchem.2020.00087/fullrelaxin-3RXFP3graftingapaminVhTIdisulfide-scaffold
spellingShingle Han Siean Lee
Michael Postan
Angela Song
Richard J. Clark
Ross A. D. Bathgate
Ross A. D. Bathgate
Linda M. Haugaard-Kedström
K. Johan Rosengren
Development of Relaxin-3 Agonists and Antagonists Based on Grafted Disulfide-Stabilized Scaffolds
Frontiers in Chemistry
relaxin-3
RXFP3
grafting
apamin
VhTI
disulfide-scaffold
title Development of Relaxin-3 Agonists and Antagonists Based on Grafted Disulfide-Stabilized Scaffolds
title_full Development of Relaxin-3 Agonists and Antagonists Based on Grafted Disulfide-Stabilized Scaffolds
title_fullStr Development of Relaxin-3 Agonists and Antagonists Based on Grafted Disulfide-Stabilized Scaffolds
title_full_unstemmed Development of Relaxin-3 Agonists and Antagonists Based on Grafted Disulfide-Stabilized Scaffolds
title_short Development of Relaxin-3 Agonists and Antagonists Based on Grafted Disulfide-Stabilized Scaffolds
title_sort development of relaxin 3 agonists and antagonists based on grafted disulfide stabilized scaffolds
topic relaxin-3
RXFP3
grafting
apamin
VhTI
disulfide-scaffold
url https://www.frontiersin.org/article/10.3389/fchem.2020.00087/full
work_keys_str_mv AT hansieanlee developmentofrelaxin3agonistsandantagonistsbasedongrafteddisulfidestabilizedscaffolds
AT michaelpostan developmentofrelaxin3agonistsandantagonistsbasedongrafteddisulfidestabilizedscaffolds
AT angelasong developmentofrelaxin3agonistsandantagonistsbasedongrafteddisulfidestabilizedscaffolds
AT richardjclark developmentofrelaxin3agonistsandantagonistsbasedongrafteddisulfidestabilizedscaffolds
AT rossadbathgate developmentofrelaxin3agonistsandantagonistsbasedongrafteddisulfidestabilizedscaffolds
AT rossadbathgate developmentofrelaxin3agonistsandantagonistsbasedongrafteddisulfidestabilizedscaffolds
AT lindamhaugaardkedstrom developmentofrelaxin3agonistsandantagonistsbasedongrafteddisulfidestabilizedscaffolds
AT kjohanrosengren developmentofrelaxin3agonistsandantagonistsbasedongrafteddisulfidestabilizedscaffolds